Bearish Bets: 2 Fragile-Looking Stocks You Should Consider Shorting This Week
These names are displaying both technical and quantitative deterioration.
My Shopping List Amid This Selloff
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
GrowGeneration Remains Ready to Sprout
A fresh look at the budding hydroponic supplier.
Are Harvest Health's Legal Problems a Red Flag?
While HRVSF has navigated through numerous changes and delivered solid revenue, litigation issues are piling up.
GrowGeneration on a Tear as the Cannabis Field Expands
GRWG has no meaningful competition. The companies in the space are one-third the size and not competing on the same national scale.
Saw Your Investments Go to Pot? Consider Cannabis Tech
Here are two tech-infused names to watch this year.
Canaccord Genuity Raises U.S. Cannabis Sales Outlook
Many in the cannabis industry have been surmising that states will look to cannabis to plug any budget shortfalls.
Will Mydecine's Move Make the Market for Pharmaceutical Psilocybin Mushroom?
Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.
Stock Picking Has Become Quite Difficult
The big question is how does this action resolve itself?
After Smoke Clears, Pot Industry Could See M&A Activity Light Up
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.